Airway Clearance Therapy: Finding the Evidence

References

1. 1.↵
   1. Rubin BK

   . Physiology of airway mucus clearance. Respir Care 2002;47(7):761–768.

   OpenUrlPubMed
2. 2.↵
   1. Warwick WJ

   . Mechanisms of mucous transport. Eur J Respir Dis Suppl 1983;127:162–167.

   OpenUrlPubMed
3. 3.↵
   1. Foster WM

   . Mucociliary transport and cough in humans. Pulm Pharmacol Ther 2002;15(3):277–282.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.
   1. Zaugg M,
   2. Lucchinetti E

   . Respiratory function in the elderly. Anesthesiol Clin North America 2000;18(1):47–58.

   OpenUrlCrossRefPubMed
5. 5.
   1. Hernandez ML,
   2. Harris B,
   3. Lay JC,
   4. Bromberg PA,
   5. Diaz-Sanchez D,
   6. Devlin RB,
   7. et al

   . Comparative airway inflammatory response of normal volunteers to ozone and lipopolysaccharide challenge. Inhal Toxicol 2010;22(8):648–656.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   1. Habesoglu M,
   2. Demir K,
   3. Yumusakhuylu AC,
   4. Yilmaz AS,
   5. Oysu C

   . Does passive smoking have an effect on nasal mucociliary clearance? Otolaryngol Head Neck Surg 2012;147(1):152–156.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Chaudri MB,
   2. Liu C,
   3. Hubbard R,
   4. Jefferson D,
   5. Kinnear WJ

   . Relationship between supermaximal flow during cough and mortality in motor neurone disease. Eur Respir J 2002;19(3):434–438.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Hadjikoutis S,
   2. Wiles CM

   . Respiratory complications related to bulbar dysfunction in motor neuron disease. Acta Neurol Scand 2001;103(4):207–213.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Van der Schans CP

   . Bronchial mucus transport. Respir Care 2007;52(9):1150–1158.

   OpenUrlAbstract/FREE Full Text
10. 10.
    1. Voynow JA,
    2. Rubin BK

    . Mucins, mucus, and sputum. Chest 2009;135(2):505–512.

    OpenUrlCrossRefPubMedWeb of Science
11. 11.↵
    1. Rubin BK

    . Mucus, phlegm, and sputum in cystic fibrosis. Respir Care 2009;54(6):726–32.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. Lester MK,
    2. Flume PA

    . Airway-clearance therapy guidelines and implementation. Respir Care 2009;54(6):733–750.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. Lapin CD

    . Airway physiology, autogenic drainage, and active cycle of breathing. Respir Care 2002;47(7):778–85.

    OpenUrlPubMed
14. 14.↵
    1. Pryor JA

    . Physiotherapy for airway clearance in adults. Eur Respir J 1999;14(6):1418–1424.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. Walsh BK,
    2. Hood K,
    3. Merritt G

    . Pediatric airway maintenance and clearance in the acute care setting: how to stay out of trouble. Respir Care 2011;56(9):1424–1440.

    OpenUrlAbstract/FREE Full Text
16. 16.↵
    1. Myers TR

    . Positive expiratory pressure and oscillatory positive expiratory pressure therapies. Respir Care 2007;52(10):1308–1326.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Chatburn RL

    . High-frequency assisted airway clearance. Respir Care 2007;52(9):1224–1235.

    OpenUrlAbstract/FREE Full Text
18. 18.↵
    1. Gauld LM

    . Airway clearance in neuromuscular weakness. Dev Med Child Neurol 2009;51(5):350–355.

    OpenUrlPubMed
19. 19.↵
    1. Armengot M,
    2. Milara J,
    3. Mata M,
    4. Carda C,
    5. Cortijo J

    . Cilia motility and structure in primary and secondary ciliary dyskinesia. Am J Rhinol Allergy 2010;24(3):175–180.

    OpenUrlCrossRefPubMedWeb of Science
20. 20.↵
    1. Carlén B,
    2. Stenram U

    . Primary ciliary dyskinesia: a review. Ultrastruct Pathol 2005;29(3-4):217–220.

    OpenUrlCrossRefPubMedWeb of Science
21. 21.↵
    1. Santamaria F,
    2. Montella S,
    3. Tiddens HA,
    4. Guidi G,
    5. Casotti V,
    6. Maglione M,
    7. de Jong PA

    . Structural and functional lung disease in primary ciliary dyskinesia. Chest 2008;134(2):351–357.

    OpenUrlCrossRefPubMedWeb of Science
22. 22.↵
    1. Thomas B,
    2. Rutman A,
    3. Hirst RA,
    4. Haldar P,
    5. Wardlaw AJ,
    6. Bankart J,
    7. et al

    . Ciliary dysfunction and ultrastructural abnormalities are features of severe asthma. J Allergy Clin Immunol 2010;126(4):722–729.

    OpenUrlCrossRefPubMedWeb of Science
23. 23.↵
    1. Verra F,
    2. Escudier E,
    3. Lebargy F,
    4. Bernaudin JF,
    5. De Crémoux H,
    6. Bignon J

    . Ciliary abnormalities in bronchial epithelium of smokers, ex-smokers, and nonsmokers. Am J Respir Crit Care Med 1995;151(3 Pt 1):630–634.

    OpenUrlCrossRefPubMedWeb of Science
24. 24.↵
    1. Jeffery PK

    . Comparative morphology of the airways in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994;150(5 Pt 2):S6–S13.

    OpenUrlPubMedWeb of Science
25. 25.↵
    1. Boucher RC

    . Evidence for airway surface dehydration as the initiating event in CF airway disease. J Intern Med 2007;261(1):5–16.

    OpenUrlCrossRefPubMedWeb of Science
26. 26.↵
    1. Boucher RC

    . Cystic fibrosis: a disease of vulnerability to airway surface dehydration. Trends Mol Med 2007;13(6):231–240.

    OpenUrlCrossRefPubMedWeb of Science
27. 27.↵
    1. Rubin BK

    . Mucus structure and properties in cystic fibrosis. Paediatr Respir Rev 2007;8(1):4–7.

    OpenUrlCrossRefPubMedWeb of Science
28. 28.↵
    1. Belessis Y,
    2. Dixon B,
    3. Hawkins G,
    4. Pereira J,
    5. Peat J,
    6. MacDonald R,
    7. et al

    . Early cystic fibrosis lung disease detected by bronchoalveolar lavage and lung clearance index. Am J Respir Crit Care Med 2012;185(8):862–873.

    OpenUrlCrossRefPubMedWeb of Science
29. 29.↵
    1. Regamey N,
    2. Tsartsali L,
    3. Hilliard TN,
    4. Fuchs O,
    5. Tan HL,
    6. Zhu J,
    7. Qiu YS,
    8. Alton EW,
    9. Jeffery PK,
    10. Bush A,
    11. Davies JC

    . Distinct patterns of inflammation in the airway lumen and bronchial mucosa of children with cystic fibrosis. Thorax 2012;67(2):164–170.

    OpenUrlAbstract/FREE Full Text
30. 30.↵
    1. Rubin BK

    . The role of mucus in cough research. Lung 2010;188(Suppl 1):S69–S72.

    OpenUrlPubMed
31. 31.↵
    1. Zimmer MB,
    2. Nantwi K,
    3. Goshgarian HG

    . Effect of spinal cord injury on the respiratory system: basic research and current clinical treatment options. J Spinal Cord Med 2007;30(4):319–330.

    OpenUrlPubMedWeb of Science
32. 32.↵
    1. Brown R,
    2. DiMarco AF,
    3. Hoit JD,
    4. Garshick E

    . Respiratory dysfunction and management in spinal cord injury. Respir Care 2006;51(8):853–868.

    OpenUrlAbstract/FREE Full Text
33. 33.↵
    1. Fairclough RJ,
    2. Bareja A,
    3. Davies KE

    . Progress in therapy for Duchenne muscular dystrophy. Exp Physiol 2011;96(11):1101–1113.

    OpenUrlCrossRefPubMedWeb of Science
34. 34.↵
    1. Chandrasoma B,
    2. Balfe D,
    3. Naik T,
    4. Elsayegh A,
    5. Lewis M,
    6. Mosenifar Z

    . Pulmonary function in patients with amyotrophic lateral sclerosis at disease onset. Monaldi Arch Chest Dis 2012;77(3-4):129–133.

    OpenUrlPubMed
35. 35.↵
    1. Beardsmore CS,
    2. Wimpress SP,
    3. Thomson AH,
    4. Patel HR,
    5. Goodenough P,
    6. Simpson H

    . Maximum voluntary cough: an indication of airway function. Bull Eur Physiopathol Respir 1987;23(5):465–472.

    OpenUrlPubMedWeb of Science
36. 36.↵
    1. Chaudri MB,
    2. Liu C,
    3. Hubbard R,
    4. Jefferson D,
    5. Kinnear WJ

    . Relationship between supramaximal flow during cough and mortality in motor neurone disease. Eur Respir J 2002;19(3):434–438.

    OpenUrlAbstract/FREE Full Text
37. 37.↵
    1. Davis PB

    . Cystic fibrosis since 1938. Am J Respir Crit Care Med 2006;173(5):475–482.

    OpenUrlCrossRefPubMedWeb of Science
38. 38.↵
    1. Sivasothy P,
    2. Brown L,
    3. Smith IE,
    4. Shneerson JM

    . Effect of manually assisted cough and mechanical insufflation on cough flow of normal subjects, patients with chronic obstructive pulmonary disease (COPD), and patients with respiratory muscle weakness. Thorax 2001;56(6):438–444.

    OpenUrlAbstract/FREE Full Text
39. 39.↵
    1. Perrin C,
    2. Unterborn JN,
    3. Ambrosio CD,
    4. Hill NS

    . Pulmonary complications of chronic neuromuscular diseases and their management. Muscle Nerve 2004;29(1):5–27.

    OpenUrlCrossRefPubMedWeb of Science
40. 40.↵
    1. Hayes RB

    . Of studies, syntheses, synopses and systems: the “4S” evolution of services for finding the current best evidence. ACP J Club 2001;134(2):A11–A13.

    OpenUrlPubMed
41. 41.↵
    1. Pattishall EN

    . Negative clinical trials in cystic fibrosis research. Pediatrics 1990;85(3):277–281.

    OpenUrlAbstract/FREE Full Text
42. 42.↵
    1. Modi AC,
    2. Cassedy AE,
    3. Quittner AL,
    4. Accurso F,
    5. Sontag M,
    6. Koenig JM,
    7. Ittenbach RF

    . Trajectories of adherence to airway clearance therapy for patients with cystic fibrosis. J Pediatr Psychol 2010;35(9):1028–1037.

    OpenUrlAbstract/FREE Full Text
43. 43.↵
    1. Modi AC,
    2. Lim CS,
    3. Yu N,
    4. Geller D,
    5. Wagner MH,
    6. Quittner AL

    . A multi-method assessment of treatment adherence for children with cystic fibrosis. J Cyst Fibros 2006;5(3):177–185.

    OpenUrlCrossRefPubMedWeb of Science
44. 44.↵
    1. Arias Llorente RP,
    2. Bousoño García C,
    3. Díaz Martín JJ

    . Treatment compliance in children and adults with cystic fibrosis. J Cyst Fibros 2008;7(5):359–367.

    OpenUrlCrossRefPubMed
45. 45.↵
    1. Bernard RS,
    2. Cohen LL

    . Increasing adherence to cystic fibrosis treatment: a systematic review of behavioral techniques. Pediatr Pulmonol 2004;37(1):8–16.

    OpenUrlPubMedWeb of Science
46. 46.↵
    1. Kettler LJ,
    2. Sawyer SM,
    3. Winefield HR,
    4. Grenville HW

    . Determinants of adherence in adults with cystic fibrosis. Thorax 2002;57(5):459–464.

    OpenUrlAbstract/FREE Full Text
47. 47.↵
    1. Grossoehme DH,
    2. Opipari-Arrigan L,
    3. VanDyke R,
    4. Thurmond S,
    5. Seid M

    . Relationship of adherence determinants and parental spirituality in cystic fibrosis. Pediatr Pulmonol 2012;47(6):558–566.

    OpenUrlPubMed
48. 48.↵
    1. Flores JS,
    2. Teixeira FÂ,
    3. Rovedder PM,
    4. Ziegler B,
    5. Dalcin Pde T

    . Adherence to airway clearance therapies by adult cystic fibrosis patients. Respir Care 2013;58(2):279–285.

    OpenUrlAbstract/FREE Full Text
49. 49.↵
    1. Myers LB,
    2. Horn SA

    . Adherence to chest physiotherapy in adults with cystic fibrosis. J Health Psychol 2006;11(6):915–926.

    OpenUrlAbstract/FREE Full Text
50. 50.↵
    1. Hess DR

    . The evidence for secretion clearance techniques. Respir Care 2001;46(11):1276–1293.

    OpenUrlPubMed
51. 51.↵
    1. Cook DJ

    . Moving toward evidence-based practice. Respir Care 2003;48(9):859–868.

    OpenUrlAbstract/FREE Full Text
52. 52.↵
    1. McKoy NA,
    2. Saldanha IJ,
    3. Odelola OA,
    4. Robinson KA

    . Active cycle of breathing technique for cystic fibrosis. Cochrane Database Syst Rev 2012;(12):CD007862.
53. 53.↵
    1. Elkins MR,
    2. Jones A,
    3. van der Schans C

    . Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis. Cochrane Database Syst Rev 2006;(2):CD003147.
54. 54.↵
    1. Morrison L,
    2. Agnew J

    . Oscillating devices for airway clearance in people with cystic fibrosis. Cochrane Database Syst Rev 2009;(1):CD006842.
55. 55.↵
    1. Elkins M,
    2. Dentice R

    . Timing of hypertonic saline inhalation for cystic fibrosis. Cochrane Database Syst Rev 2012;(2):CD008816.
56. 56.↵
    1. Dentice R,
    2. Elkins M

    . Timing of dornase alfa inhalation for cystic fibrosis. Cochrane Database Syst Rev 2011;(5):CD007923.
57. 57.↵
    1. Main E,
    2. Prasad A,
    3. Schans C

    . Conventional chest physiotherapy compared to other airway clearance techniques for cystic fibrosis. Cochrane Database Syst Rev 2005;(1):CD002011.
58. 58.↵
    1. Osadnik CR,
    2. McDonald CF,
    3. Jones AP,
    4. Holland AE

    . Airway clearance techniques for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2012;(3):CD008328.
59. 59.↵
    1. Cool FD,
    2. Rosen MJ

    . Nonpharmacologic airway clearance therapies: ACCP evidence-based clinical practice guidelines. Chest 2006;129(1 Suppl):250S–259S.

    OpenUrlCrossRefPubMedWeb of Science
60. 60.↵
    1. Flume PA,
    2. Robinson KA,
    3. O'Sullivan BP,
    4. Finder JD,
    5. Vender RL,
    6. Willey-Courand DB,
    7. et al

    ; Clinical Practice Guidelines for Pulmonary Therapies Committee. Cystic fibrosis pulmonary guidelines: airway clearance therapies. Respir Care 2009;54(4):522–537.

    OpenUrlAbstract/FREE Full Text
61. 61.↵
    1. Kallam A,
    2. Meyerink K,
    3. Modrykamien AM

    . Physician-ordered aerosol therapy versus respiratory therapist-driven aerosol protocol: the effect on resource utilization. Respir Care 2013;58(3):431–437.

    OpenUrlAbstract/FREE Full Text
62. 62.
    1. Colice GL,
    2. Carnathan B,
    3. Sung J,
    4. Paramore LC

    . A respiratory therapist-directed protocol for managing inpatients with asthma and COPD incorporating a long-acting bronchodilator. J Asthma 2005;42(1):29–34.

    OpenUrlPubMed
63. 63.
    1. Drescher GS,
    2. Carnathan BJ,
    3. Imus S,
    4. Colice GL

    . Incorporating tiotropium into a respiratory therapist-directed bronchodilator protocol for managing in-patients with COPD exacerbations decreases bronchodilator costs. Respir Care 2008;53(12):1678–1684.

    OpenUrlAbstract/FREE Full Text
64. 64.↵
    1. Kollef MH,
    2. Shapiro SD,
    3. Clinkscale D,
    4. Cracchiolo L,
    5. Clayton D,
    6. Wilner R,
    7. Hossin L

    . The effect of respiratory therapist-initiated treatment protocols on patient outcomes and resource utilization. Chest 2000;117(2):467–475.

    OpenUrlCrossRefPubMedWeb of Science
65. 65.↵
    1. Shapiro BA,
    2. Cane RD,
    3. Peterson J,
    4. Weber D

    . Authoritative medical direction can assure cost-beneficial bronchial hygiene therapy. Chest 1988;93(5):1038–1042.

    OpenUrlCrossRefPubMed
66. 66.
    1. Alexander E,
    2. Weingarten S,
    3. Mohsenifar Z

    . Clinical strategies to reduce utilization of chest physiotherapy without compromising patient care. Chest 1996;110(3):430–432.

    OpenUrlCrossRefPubMedWeb of Science
67. 67.
    1. Homnock DN

    . Making airway clearance successful. Paediatr Respir Rev 2007;8(1):40–45.

    OpenUrlCrossRefPubMedWeb of Science
68. 68.↵
    1. White D,
    2. Stiller K,
    3. Haensel N

    . Adherence of adult cystic fibrosis patients with airway clearance and exercise regimens. J Cyst Fibros 2007;6(3):163–170.

    OpenUrlPubMed
69. 69.↵
    1. Christman SL,
    2. Volsko TA

    . Evaluation of an oxygen protocol in long-term care. Respir Care 2006;51(12):1424–1431.

    OpenUrlAbstract/FREE Full Text